JUNS Insider Trading Activity and SEC Form 4 Filings
JUNS insider trading summary
No open-market insider purchases or sales of Jupiter Neurosciences, Inc. (JUNS) have been reported on SEC Form 4 in the past 12 months.
Latest JUNS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 1, 2025 | Christer Rosen | CEO and Chairman | Buy | $3K (3,100 @ $1.02) |
| Jul 1, 2025 | Alison D. Silva | Pres + Chief Business Officer | Buy | $257 (250 @ $1.03) |
| Jul 1, 2025 | Alison D. Silva | Pres + Chief Business Officer | Buy | $259 (250 @ $1.03) |
| Jul 1, 2025 | Christer Rosen | CEO and Chairman | Buy | $505 (500 @ $1.01) |
| Jul 1, 2025 | Alison D. Silva | Pres + Chief Business Officer | Buy | $257 (250 @ $1.03) |
| Jun 30, 2025 | Alison D. Silva | Pres + Chief Business Officer | Buy | $258 (250 @ $1.03) |
| Jun 30, 2025 | Alison D. Silva | Pres + Chief Business Officer | Buy | $255 (250 @ $1.02) |
| Jun 30, 2025 | Alison D. Silva | Pres + Chief Business Officer | Buy | $259 (250 @ $1.04) |
| Jun 30, 2025 | Alison D. Silva | Pres + Chief Business Officer | Buy | $102 (100 @ $1.02) |
| Jun 30, 2025 | Christer Rosen | CEO and Chairman | Buy | $2K (2,000 @ $1.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.